🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
This is a Phase 1 open-label, multicenter study of the safety and tolerabil...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2021-08-19
Trial ID
NCT04892043
Treatments Being Tested
This research clinical trial is studying the creation and administration of...
Status
Terminated
Location
Boston Children's Hospital
Start Date
2020-01-29
Trial ID
NCT04239040
Treatments Being Tested
Immunotherapy with immune checkpoint inhibitors, including pembrolizumab, h...
Status
Active Not Recruiting
Location
UPMC Hillman Cancer Center
Start Date
2023-03-30
Trial ID
NCT05467670
Treatments Being Tested
This study is being done to learn more about a new drug called Bapotulimab ...
Status
Completed
Location
University of Arizona Cancer Center
Start Date
2018-09-12
Trial ID
NCT03666273
Treatments Being Tested
The purpose of this study is to find out if microtransplantation (MST) in c...
Status
Withdrawn
Location
Duke University
Start Date
2020-07-10
Trial ID
NCT03920631
Treatments Being Tested
This is a phase I, open label, plus expansion clinical trial evaluating the...
Status
Recruiting
Location
Children's Health Orange County (CHOC)
Start Date
2022-01-10
Trial ID
NCT04943848
Treatments Being Tested
The development of Immune Checkpoint Blockade (ICB) is a revolution in medi...
Status
Completed
Location
Institut Paoli-Calmettes
Start Date
2018-01-29
Trial ID
NCT03595813
Treatments Being Tested
The researchers are doing this study to find out whether the combination of...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-11-07
Trial ID
NCT07227636
Treatments Being Tested
This open labelled first in human dose phase 1/2a study is designed to eval...
Status
Completed
Location
Charité Research Organisation, Campus Benjamin Franklin
Start Date
2018-04-04
Trial ID
NCT03548467
Treatments Being Tested